Transcriptional mechanisms of resistance to anti-PD-1 therapy Journal Article


Authors: Ascierto, M. L.; Makohon-Moore, A.; Lipson, E. J.; Taube, J. M.; McMiller, T. L.; Berger, A. E.; Fan, J.; Kaunitz, G. J.; Cottrell, T. R.; Kohutek, Z. A.; Favorov, A.; Makarov, V.; Riaz, N.; Chan, T. A.; Cope, L.; Hruban, R. H.; Pardoll, D. M.; Taylor, B. S.; Solit, D. B.; Iacobuzio-Donahue, C. A.; Topalian, S. L.
Article Title: Transcriptional mechanisms of resistance to anti-PD-1 therapy
Abstract: Purpose: To explore factors associated with response and resistance to anti-PD-1 therapy, we analyzed multiple disease sites at autopsy in a patient with widely metastatic melanoma who had a heterogeneous response. Materials and Methods: Twenty-six melanoma specimens (four premortem, 22 postmortem) were subjected to whole exome sequencing. Candidate immunologic markers and gene expression were assessed in 10 cutaneous metastases showing response or progression during therapy. Results: The melanoma was driven by biallelic inactivation of NF1. All lesions had highly concordant mutational profiles and copy number alterations, indicating linear clonal evolution. Expression of candidate immunologic markers was similar in responding and progressing lesions. However, progressing cutaneous metastases were associated with overexpression of genes associated with extracellular matrix and neutrophil function. Conclusions: Although mutational and immunologic differences have been proposed as the primary determinants of heterogeneous response/resistance to targeted therapies and immunotherapies, respectively, differential lesional gene expression profiles may also dictate anti-PD-1 outcomes. (C) 2017 AACR. See related commentary by Wilmott et al., p. 2921
Keywords: melanoma; metastasis; evolution; mutations; expression; lung-cancer; pancreatic-cancer; immune checkpoint blockade; large gene lists; pd-1 blockade
Journal Title: Clinical Cancer Research
Volume: 23
Issue: 12
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2017-06-15
Start Page: 3168
End Page: 3180
Language: English
ACCESSION: WOS:000403330000033
DOI: 10.1158/1078-0432.ccr-17-0270
PROVIDER: wos
PMCID: PMC5474192
PUBMED: 28193624
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. David Solit
    781 Solit
  3. Nadeem Riaz
    422 Riaz
  4. Zachary Adam Kohutek
    26 Kohutek
  5. Barry Stephen Taylor
    238 Taylor
  6. Vladimir Makarov
    57 Makarov